Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending August 23, 2020 WHO-defined IDH molecular subgroups predict adjuvant chemotherapy benefits in low-grade glioma, Diabetes plus weight loss equals increased risk of pancreatic cancer, Incidence, prognosis of second lung cancers support long-term surveillance, Beyond baseline, DBT no better than mammography for dense breasts, Meta-analysis suggests ibrutinib is safe, effective in DLBCL, More must reads Must reads for theWeek ending August 16, 2020 Polygenic risk score may predict VTE in adolescents, but not adults, with ALL, Determining cause of skin lesions in COVID-19 patients remains challenging, Since COVID-19 onset, admissions for MI are down, mortality rates are up, Elotuzumab-based therapy may benefit post-transplant response in multiple myeloma, BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients, More must readsMust reads for theWeek ending August 9, 2020 Many children with COVID-19 present without classic symptoms, System provides ‘faster, less invasive’ method for breast cancer detection, Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy, Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19, How prostate cancer treatments affect quality of life, More must readsMust reads for theWeek ending August 2, 2020 Better continence rate gives robotic prostatectomy the edge, More data needed to better understand COVID-19 skin manifestations, Higher death rate seen in cancer patients with nosocomial COVID-19, Sleepless in the pandemic, Large cohort study: Bevacizumab safe, effective for severe HHT bleeds, More must readsMust reads for theWeek ending July 26, 2020 Small NY study: Mother-baby transmission of COVID-19 not seen, Men occupy most leadership roles in medicine, Intravesical BCG dosing frequency ‘critical’ in bladder cancer, Low-dose prasugrel preserves efficacy but lowers bleeding in elderly, Oral selinexor induced durable responses on relapsed or refractory DLBCL patients, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 last »